Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations von Spring, Laura M., Zangardi, Mark L., Moy, Beverly, Bardia, Aditya

Volltext

Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report von Sin, Jonathan H., Zangardi, Mark L.

Volltext

Pilot Randomized Trial of a Pharmacy Intervention for Older Adults with Cancer von Nipp, Ryan D., Ruddy, Margaret, Fuh, Charn‐Xin, Zangardi, Mark L., Chio, Christine, Kim, E. Bridget, Li, Barbara Kong Mui, Long, Ying, Blouin, Gayle C., Lage, Daniel, Ryan, David P., Greer, Joseph A., El‐Jawahri, Areej, Temel, Jennifer S.

Volltext

Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations von Spring, Laura M, Zangardi, Mark L, Moy, Beverly, Bardia, Aditya

Volltext bestellen

A multicenter analysis of abemaciclib after progression on palbociclib in patients (pts) with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC) von Wander, Seth Andrew, Zangardi, Mark, Niemierko, Andrzej, Kambadakone, Avinash, Kim, Leslie SL, Xi, Jing, Pandey, Apurva Kumari, Spring, Laura, Stein, Casey, Juric, Dejan, Kuter, Irene, Moy, Beverly, Mulvey, Therese Marie, Vidula, Neelima, Isakoff, Steven J., Yuen, Megan, Brufsky, Adam, Ma, Cynthia X., O'Shaughnessy, Joyce, Bardia, Aditya

Volltext